These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26768065)

  • 41. [Treatment of eye allergies].
    Kari O; Saari KM
    Duodecim; 2012; 128(3):291-7. PubMed ID: 22428383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapeutic use of topical cyclosporine.
    Kaan G; Ozden O
    Ann Ophthalmol; 1993 May; 25(5):182-6. PubMed ID: 8517589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topical bromfenac sodium for long-term management of vernal keratoconjunctivitis.
    Uchio E; Itoh Y; Kadonosono K
    Ophthalmologica; 2007; 221(3):153-8. PubMed ID: 17440276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis.
    Kheirkhah A; Zavareh MK; Farzbod F; Mahbod M; Behrouz MJ
    Eye (Lond); 2011 Jul; 25(7):872-80. PubMed ID: 21475312
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tacrolimus versus Cyclosporine- Comparative Evaluation as First line drug in Vernal keratoconjuctivitis.
    Kumari R; Saha BC; Sinha BP; Mohan N
    Nepal J Ophthalmol; 2017 Jul; 9(18):128-135. PubMed ID: 29634701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of a Cationic Emulsion of Cyclosporine in Moderate Vernal Keratoconjunctivitis.
    Caputo R; Di Grande L; de Libero C; Marziali E; Mori F; Masini M
    Cornea; 2024 Feb; 43(2):228-232. PubMed ID: 37747690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical immunomodulators in the management of allergic eye diseases.
    Erdinest N; Solomon A
    Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):457-63. PubMed ID: 25054831
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cyclosporine eye drops: A 4-year retrospective study (2009-2013)].
    Kauss Hornecker M; Charles Weber S; Brandely Piat ML; Darrodes M; Jomaa K; Chast F
    J Fr Ophtalmol; 2015 Oct; 38(8):700-8. PubMed ID: 26371985
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term use of topical tacrolimus ointment: a safe and effective option for the treatment of vernal keratoconjunctivitis.
    Müller GG; José NK; de Castro RS; de Holanda EC
    Arq Bras Oftalmol; 2019; 82(2):119-123. PubMed ID: 30698232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [0.05% cyclosporine a for treatment of chronic severe ocular surface disease].
    Nochez Y; Denoyer A; Pisella PJ
    Can J Ophthalmol; 2009 Aug; 44(4):406-11. PubMed ID: 19606161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of medical treatments for vernal keratoconjunctivitis: A systematic review and meta-analysis.
    Roumeau I; Coutu A; Navel V; Pereira B; Baker JS; Chiambaretta F; Bremond-Gignac D; Dutheil F
    J Allergy Clin Immunol; 2021 Sep; 148(3):822-834. PubMed ID: 33819510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical cyclosporine in the management of shield ulcers.
    Cetinkaya A; Akova YA; Dursun D; Pelit A
    Cornea; 2004 Mar; 23(2):194-200. PubMed ID: 15075890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical debridement plus topical cyclosporine A in the treatment of vernal shield ulcers.
    Caputo R; Pucci N; Mori F; De Libero C; Di Grande L; Bacci GM
    Int J Immunopathol Pharmacol; 2012; 25(3):775-80. PubMed ID: 23058030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis.
    Secchi AG; Tognon MS; Leonardi A
    Am J Ophthalmol; 1990 Dec; 110(6):641-5. PubMed ID: 2248328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunopathological Features of Severe Chronic Atopic Keratoconjunctivitis and Effects of Topical Cyclosporine Treatment.
    Utine CA; Stern M; Akpek EK
    Ocul Immunol Inflamm; 2019; 27(7):1184-1193. PubMed ID: 30189151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis.
    el-Asrar AM; Tabbara KF; Geboes K; Missotten L; Desmet V
    Am J Ophthalmol; 1996 Feb; 121(2):156-61. PubMed ID: 8623884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monotherapy of topical tacrolimus 0.03% in the treatment of vernal keratoconjunctivitis in the pediatric population.
    Samyukta SK; Pawar N; Ravindran M; Allapitchai F; Rengappa R
    J AAPOS; 2019 Feb; 23(1):36.e1-36.e5. PubMed ID: 30664932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cyclosporin A 2% eyedrops in therapy of atopic and vernal keratoconjunctivitis].
    Tomida I; Schlote T; Bräuning J; Heide PE; Zierhut M
    Ophthalmologe; 2002 Oct; 99(10):761-7. PubMed ID: 12376851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis.
    Daniell M; Constantinou M; Vu HT; Taylor HR
    Br J Ophthalmol; 2006 Apr; 90(4):461-4. PubMed ID: 16547328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population.
    Lambiase A; Minchiotti S; Leonardi A; Secchi AG; Rolando M; Calabria G; Orsoni J; Zola E; Ferreri G; Aragona P; Reibaldi A; Chisari G; Bonini S
    Ophthalmic Epidemiol; 2009; 16(1):38-41. PubMed ID: 19191180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.